Swiss Life Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Buy |
38,401
+7,295
| +23% | +$4.09M | 0.08% | 185 |
|
|
2026
Q1 | $17.5M | Sell |
31,106
-5,344
| -15% | -$3.43M | 0.09% | 186 |
|
|
2025
Q4 | $24.7M | Buy |
36,450
+9,910
| +37% | +$6.75M | 0.13% | 133 |
|
|
2025
Q3 | $17M | Buy |
26,540
+5,081
| +24% | +$3.08M | 0.09% | 179 |
|
|
2025
Q2 | $11.5M | Sell |
21,459
-6,737
| -24% | -$3.22M | 0.07% | 218 |
|
|
2025
Q1 | $11.8M | Buy |
28,196
+1,305
| +5% | +$567K | 0.09% | 187 |
|
|
2024
Q4 | $11.1M | Buy |
26,891
+6,476
| +32% | +$2.84M | 0.08% | 180 |
|
|
2024
Q3 | $10.3M | Buy |
20,415
+4,247
| +26% | +$2.06M | 0.12% | 165 |
|
|
2024
Q2 | $7.88M | Buy |
16,168
+276
| +2% | +$139K | 0.09% | 192 |
|
|
2024
Q1 | $8.58M | Sell |
15,892
-14,052
| -47% | -$7.68M | 0.12% | 159 |
|
|
2023
Q4 | $16.6M | Buy |
29,944
+4,134
| +16% | +$1.94M | 0.2% | 113 |
|
|
2023
Q3 | $11.3M | Buy |
25,810
+3,470
| +16% | +$1.73M | 0.17% | 135 |
|
|
2023
Q2 | $11.2M | Buy |
22,340
+3,316
| +17% | +$1.59M | 0.17% | 156 |
|
|
2023
Q1 | $9.51M | Buy |
19,024
+10,471
| +122% | +$5.01M | 0.14% | 185 |
|
|
2022
Q4 | $3.49M | Sell |
8,553
-1,797
| -17% | -$698K | 0.06% | 340 |
|
|
2022
Q3 | $3.37M | Sell |
10,350
-11,149
| -52% | -$4.1M | 0.06% | 335 |
|
|
2022
Q2 | $7.54M | Buy |
21,499
+10,246
| +91% | +$4.18M | 0.12% | 197 |
|
|
2022
Q1 | $6.15M | Sell |
11,253
-779
| -6% | -$410K | 0.09% | 248 |
|
|
2021
Q4 | $7.92M | Sell |
12,032
-4,259
| -26% | -$2.67M | 0.1% | 232 |
|
|
2021
Q3 | $10.1M | Sell |
16,291
-2,345
| -13% | -$1.58M | 0.14% | 180 |
|
|
2021
Q2 | $9.24M | Sell |
18,636
-866
| -4% | -$478K | 0.09% | 214 |
|
|
2021
Q1 | $9.54M | Buy |
19,502
+5,370
| +38% | +$2.69M | 0.14% | 191 |
|
|
2020
Q4 | $7.06M | Buy |
14,132
+13,160
| +1,354% | +$5.89M | 0.1% | 227 |
|
|
2020
Q3 | $382K | Sell |
972
-1,004
| -51% | -$371K | 0.01% | 436 |
|
|
2020
Q2 | $653K | Buy |
1,976
+146
| +8% | +$42.3K | 0.01% | 405 |
|
|
2020
Q1 | $443K | Sell |
1,830
-56
| -3% | -$14.6K | 0.01% | 429 |
|
|
2019
Q4 | $493K | Sell |
1,886
-277
| -13% | -$73K | 0.01% | 448 |
|
|
2019
Q3 | $588K | Sell |
2,163
-293
| -12% | -$81.5K | 0.01% | 432 |
|
|
2019
Q2 | $674K | Buy |
2,456
+1,045
| +74% | +$257K | 0.01% | 429 |
|
|
2019
Q1 | $315K | Buy |
+1,411
| New | +$291K | ﹤0.01% | 459 |
|
|
2018
Q4 | – | Sell |
-8,494
| Closed | -$2.12M | – | 321 |
|
|
2018
Q3 | $2.12M | Buy |
8,494
+6,878
| +426% | +$1.67M | 0.03% | 305 |
|
|
2018
Q2 | $352K | Sell |
1,616
-22
| -1% | -$4.53K | 0.01% | 467 |
|
|
2018
Q1 | $313K | Buy |
+1,638
| New | +$302K | 0.01% | 453 |
|
|
2017
Q3 | – | Sell |
-5,712
| Closed | -$921K | – | 488 |
|
|
2017
Q2 | $921K | Sell |
5,712
-1,912
| -25% | -$311K | 0.02% | 354 |
|
|
2017
Q1 | $1.18M | Buy |
+7,624
| New | +$1.05M | 0.03% | 247 |
|
|
2016
Q4 | – | Sell |
-5,514
| Closed | -$621K | – | 446 |
|
|
2016
Q3 | $621K | Buy |
5,514
+1,697
| +44% | +$179K | 0.02% | 315 |
|
|
2016
Q2 | $354K | Buy |
+3,817
| New | +$328K | 0.01% | 286 |
|
Other funds holding IDXX
Swiss Life Asset Management's IDXX Position: Q2 2026 in Review
Swiss Life Asset Management increased its Idexx Laboratories (IDXX) stake by 23% in Q2 2026, buying an estimated $4.09M and bringing the position to 38,401 shares worth $20.2M. The position accounts for 0.08% of the portfolio, ranked #185.
Swiss Life Asset Management first reported a position in IDXX in Q2 2016 and has held it in 37 quarters since. The position peaked at $24.7M in Q4 2025. 897 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Swiss Life Asset Management held 38,401 shares of Idexx Laboratories worth $20.2M as of Q2 2026.
- Swiss Life Asset Management bought 7,295 Idexx Laboratories shares in Q2 2026, an estimated $4.09M.
- Idexx Laboratories made up 0.08% of Swiss Life Asset Management's portfolio in Q2 2026, its #185 holding.
- Swiss Life Asset Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 37 quarters since.
- Swiss Life Asset Management's Idexx Laboratories position peaked at $24.7M in Q4 2025.
- 897 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.